Additional work in mouse models has also demonstrated that this diet or pharmacological suppression of blood glucose levels can improve sensitivity to PI3K pathway inhibition through the inhibition of PI3K-mediated insulin feedback, which could be an interesting approach for PTEN-deficient prostate cancer [217]. This evidence concerns the gene PIK3CD and Familial prostate cancer.